Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can patients power their own obesity research?

NCT ID NCT07759544

Knowledge-focused Sponsor: IQVIA RDS Spain, SL Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This observational pilot study explores whether adults with obesity in England, France, and Germany can participate in research entirely from home. Participants will authorize access to their medical records and complete an online questionnaire about their health, quality of life, and experiences like 'food noise.' The goal is to see if this remote, participant-driven method can efficiently gather accurate and complete data for future obesity research. There is no treatment involved—just data collection.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this approach could make it easier and faster to gather real-world health data from people with obesity, potentially improving future research and care.
What could go wrong
This is a small pilot study, so results may not apply broadly. The success depends on participants' willingness to share medical records and on how well those records match self-reported information.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 105 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants will be recruited remotely in England, France and Germany by IQVIA Global Perspectives through patient advocacy groups, research recruitment services (OneKey), and existing patient panels (IQVIA Ltd's Global Perspectives Patient Community). Potential participants will receive an email containing a plain-language description of the study and a link to a screening platform. After providing a brief study-specific consent, they will complete a short pre-screening questionnaire. Those who appear eligible and wish to continue will receive an invitation to the IQVIA Health Research Space (HRS) platform. There, participants will complete the electronic informed consent process, provide authorization for medical record access (where applicable), and undergo eligibility assessment based on the study inclusion and exclusion criteria. Only participants who meet all eligibility requirements and provide informed consent will be enrolled in the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Resident in England, France, or Germany * Self-reported height and weight corresponding to a calculated BMI ≥27 kg/m² Exclusion Criteria: * Unable to provide electronic informed consent form (ICF) * Unable to name at least one HCP involved in their care and the affiliated institution, where applicable * Unwilling to authorise medical records access via DSAR (where applicable) or direct upload * Unable to complete online surveys (approximately 30 minutes) on own device (computer, smartphone, or tablet) * Participants whose HCPs are exclusively located outside the participant's country of residence, where applicable

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity (disorder) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity (disorder) Overweight/obesity

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.